» Articles » PMID: 29773527

Acceptability and Feasibility of Real-Time Antiretroviral Therapy Adherence Interventions in Rural Uganda: Mixed-Method Pilot Randomized Controlled Trial

Overview
Date 2018 May 19
PMID 29773527
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Wireless electronic adherence monitors can detect antiretroviral therapy (ART) adherence lapses and trigger interventions in real time, thus potentially avoiding unnecessary HIV viremia. Evidence about the acceptability and feasibility of these monitors and associated interventions, however, is limited.

Objective: The aim of this study was to assess the acceptability and feasibility of real-time adherence monitoring linked to text messaging (short message service, SMS) reminders and notifications to support adherence among individuals living with HIV who are taking ART in rural southwestern Uganda.

Methods: Individuals living with HIV who were initiating ART were enrolled in a pilot randomized controlled trial and followed up for 9 months. Participants received a real-time adherence monitor and were randomized to one of the following study arms: (1) scheduled SMS, (2) SMS triggered by missed or delayed doses, or (3) no SMS. SMS notifications were also sent to 45 patient-identified social supporters for sustained adherence lapses in the scheduled SMS and triggered SMS arms. Study participants and social supporters participated in qualitative semistructured in-depth interviews on acceptability and feasibility of this technology. An inductive, content analytic approach, framed by the unified theory of acceptance and use of technology model, was used to analyze qualitative data. Quantitative feasibility data, including device functionality and SMS tracking data, were recorded based upon device metrics collected electronically and summarized descriptively.

Results: A total of 63 participants participated in the study. Participants reported that real-time monitoring intervention linked to SMS reminders and notifications are generally acceptable; the predominant feedback was perceived utility-the intervention was beneficial in motivating and reminding patients to take medication, as well as enabling provision of social support. The intervention was found to be technically feasible, as data were obtained from most participants as expected most of the time. Potential challenges included the impact of the technology on confidentiality, shared phone ownership, usability skills, and availability of electricity.

Conclusions: Real-time adherence monitoring integrated with SMS reminders and social support notifications is a generally acceptable (based primarily on perceived utility) and feasible intervention in a resource-limited country. Future efforts should focus on optimized device design, user training to overcome the challenges we encountered, cost effectiveness studies, as well as studying the monitoring aspect of the device without accompanying interventions.

Trial Registration: ClinicalTrials.gov NCT01957865; https://clinicaltrials.gov/ct2/show/NCT01957865 (Archived by WebCite at http://www.webcitation.org/6zFiDlXDa).

Citing Articles

Appraising perception, accessibility and uptake of DAT among patients with TB.

Ogbudebe C, Odume B, Gordon I, Chukwuogo O, Nwokoye N, Useni S Public Health Action. 2024; 14(2):66-70.

PMID: 38957499 PMC: 11216292. DOI: 10.5588/pha.24.0009.


Acceptability of a Digital Adherence Tool Among Patients With Tuberculosis and Tuberculosis Care Providers in Kilimanjaro Region, Tanzania: Mixed Methods Study.

Mtenga A, Maro R, Dillip A, Msoka P, Emmanuel N, Ngowi K Online J Public Health Inform. 2024; 16:e51662.

PMID: 38922643 PMC: 11237791. DOI: 10.2196/51662.


Acceptability and feasibility of long-term, real-time electronic adherence monitoring of HIV pre-exposure prophylaxis (PrEP) use among young women in Kenya: A mixed methods study.

Ogello V, Rono B, Ngure K, Sedah E, Thuo N, Musinguzi N PLoS One. 2024; 19(3):e0299168.

PMID: 38451884 PMC: 10919630. DOI: 10.1371/journal.pone.0299168.


Development of a customized m-Health-based intervention to reduce loss to follow-up among patients undergoing treatment for cervical lesions at a rural referral Hospital, South Western Uganda.

Ssedyabane F, Randall T, Kajabwangu R, Namuli A, Tusubira D, Kakongi N Gynecol Oncol Rep. 2024; 52:101338.

PMID: 38435345 PMC: 10907155. DOI: 10.1016/j.gore.2024.101338.


Differentiated service delivery framework for people with multidrug-resistant tuberculosis and HIV co-infection.

Reis K, Wolf A, Perumal R, Seepamore B, Guzman K, Ross J J Acquir Immune Defic Syndr. 2024; .

PMID: 38323838 PMC: 11300702. DOI: 10.1097/QAI.0000000000003394.


References
1.
Dowshen N, Kuhns L, Johnson A, Holoyda B, Garofalo R . Improving adherence to antiretroviral therapy for youth living with HIV/AIDS: a pilot study using personalized, interactive, daily text message reminders. J Med Internet Res. 2012; 14(2):e51. PMC: 3376506. DOI: 10.2196/jmir.2015. View

2.
Mills E, Lester R, Ford N . Promoting long term adherence to antiretroviral treatment. BMJ. 2012; 344:e4173. DOI: 10.1136/bmj.e4173. View

3.
Maduka O, Tobin-West C . Adherence counseling and reminder text messages improve uptake of antiretroviral therapy in a tertiary hospital in Nigeria. Niger J Clin Pract. 2013; 16(3):302-8. DOI: 10.4103/1119-3077.113451. View

4.
da Costa T, Barbosa B, Gomes E Costa D, Sigulem D, de Fatima Marin H, Castelo Filho A . Results of a randomized controlled trial to assess the effects of a mobile SMS-based intervention on treatment adherence in HIV/AIDS-infected Brazilian women and impressions and satisfaction with respect to incoming messages. Int J Med Inform. 2012; 81(4):257-69. PMC: 3766367. DOI: 10.1016/j.ijmedinf.2011.10.002. View

5.
Campbell J, Eyal N, Musiimenta A, Haberer J . Ethical Questions in Medical Electronic Adherence Monitoring. J Gen Intern Med. 2015; 31(3):338-42. PMC: 4762813. DOI: 10.1007/s11606-015-3502-4. View